13F-HR filed by NEXTBio Capital Management LP
NEXTBio Capital Management LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-13, with 23 holding rows worth $170,491,823.
- Accession
- 0001172661-26-000761
- Filer
- CIK 2038158
- Filed
- 2026-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 23 entries on the cover page, a total value of $170,491,823 stated on the cover page (in dollars after the unit check, H1), rows summing to $170,491,823 with VALUE read as dollars as filed, 13F file number 028-26345. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 551,190 | $22,268,076 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 229,619 | $20,054,923 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 999,967 | $13,079,568 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 321,983 | $11,691,203 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 3,149,907 | $11,497,161 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 1,307,330 | $10,092,588 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 82,686 | $8,654,744 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 183,704 | $8,233,613 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 67,586 | $7,234,405 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 94,443 | $6,568,511 | dollars as filed | |
| INVENTIVA SA | 46124U107 | ADS | 1,298,701 | $6,038,960 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 1,114,005 | $5,982,207 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 752,631 | $5,193,154 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 615,720 | $5,036,590 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 372,856 | $4,422,072 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 95,485 | $4,405,678 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 228,286 | $3,908,256 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 95,819 | $3,403,491 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 42,778 | $3,397,001 | dollars as filed | |
| OCULIS HOLDING AG | H5870P102 | CMN | 149,750 | $2,990,508 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 163,362 | $2,881,706 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 131,796 | $2,128,505 | dollars as filed | |
| ADICET BIO INC | 007002207 | COM NEW | 157,827 | $1,328,903 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001172661-26-000761 | this filing | 2026-02-13 | acceptance time not in the bulk data set |